Broadcast

New Horizons in Obesity Management (NHOM) 2026

Angela Fitch, Richard Hobbs, Nikolaus Marx, et al

About

The high prevalence and increasing incidence of obesity and associated cardiovascular risk emphasises the need to focus on obesity reduction in this high-risk population.

Metabolic syndrome (MetS) is the coexistence of obesity-related cardiovascular risk factors including hypertension, diabetes and dyslipidaemia. MetS is a precursor for atherosclerosis, including premature coronary artery disease, and cardiovascular mortality.
 

Articles

Targeting Obesity for Heart Failure

Published:

23 December 2025

Citation:

European Cardiology Review 2025;20:e38.

Obesity and CKD: The Dual Epidemic in Cardiovascular Health

Published:

17 October 2025

Citation:

European Cardiology Review 2025;20:e28.

Maternal Cardiac Function in Pregnancies With Metabolic Disorders

Published:

19 June 2024

Citation:

European Cardiology Review 2024;19:e08.

Treatment Options and Continuity of Care in MAFLD

Published:

19 June 2024

Citation:

European Cardiology Review 2024;19:e06.